Regarding the cancer medicine Revlimid, Reddy’s Laboratories Ltd arm is the target of an antitrust complaint in the US. [Representational image only Credit : Unsplash/] Courtesy : TH ; 09/10/2023
Tue. Oct 13th, 2026
Regarding the cancer medicine Revlimid, Reddy’s Laboratories Ltd arm is the target of an antitrust complaint in the US. [Representational image only Credit : Unsplash/] Courtesy : TH ; 09/10/2023
